Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis-Reference-Cited by-同舟云学术

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis

Published:2023-11 Issue:11 Volume:26 Page:107970
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Anpalakhan Shobana,Signori Alessio,Cortellini Alessio,Verzoni Elena,Giusti Raffaele,Aprile Giuseppe,Ermacora Paola,Catino Annamaria,Pipitone Stefania,Di Napoli Marilena,Scotti Vieri,Mazzoni Francesca,Guglielmini Pamela F.,Veccia Antonello,Maruzzo Marco,Schinzari Giovanni,Casadei Chiara,Grossi Francesco,Rizzo Mimma,Montesarchio Vincenzo,Verderame Francesco,Mencoboni Manlio,Zustovich Fable,Fratino Lucia,Accettura Caterina,Cinieri Saverio,Tondini Carlo Alberto,Camerini Andrea,Banzi Maria Chiara,Sorarù Mariella,Zucali Paolo Andrea,Vignani Francesca,Ricciardi Serena,Russo Antonio,Cosenza Agnese,Di Maio Massimo,De Giorgi Ugo,Pignata Sandro,Giannarelli Diana,Pinto Carmine,Buti Sebastiano,Fornarini Giuseppe,Rebuzzi Sara Elena,Rescigno Pasquale,Addeo Alfredo^ORCID,Banna Giuseppe L.,Bersanelli Melissa

Funder

Roche

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference43 articles.

1. Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer;Zer;Clin. Lung Cancer,2018

2. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody;Suh;Cancer Immunol. Immunother.,2018

3. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer;Takeda;Thorac. Cancer,2018

4. The Relationship Between Systemic Immune Inflammatory Index and Prognosis of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review;Huang;Front. Surg.,2022

5. Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors;Rebuzzi;Crit. Rev. Oncol. Hematol.,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma;Frontiers in Oncology;2024-09-02

2. Unlocking the potential: the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as biomarkers informing immunotherapy outcomes in lung cancer patients — single oncology center experience and literature review;Oncology in Clinical Practice;2024-08-21

3. Prognostic value of systemic immune-inflammation index in patients with metastatic renal cell carcinoma treated with systemic therapy: a meta-analysis;Frontiers in Oncology;2024-06-19

4. The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy;International Journal of Clinical Oncology;2024-05-26

5. Investigation of the predictive value of systemic immune inflammation index (SII) and prognostic nutritional index (PNI) on mortality in patients with endoprosthesis after hip fracture;Medicine;2024-05-03